Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Exploratory Developmental Grant (R21) Program, RFA OH-02-001

---
identifier: "/us/fr/02-2658"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Exploratory Developmental Grant (R21) Program, RFA OH-02-001"
title_number: 0
title_name: "Federal Register"
section_number: "02-2658"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Exploratory Developmental Grant (R21) Program, RFA OH-02-001"
positive_law: false
currency: "2002-02-05"
last_updated: "2002-02-05"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-2658"
document_type: "notice"
publication_date: "2002-02-05"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "67 FR 5288"
fr_volume: 67
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Exploratory Developmental Grant (R21) Program, RFA OH-02-001

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Exploratory Developmental Grant (R21) Program, RFA OH-02-001.

*Times and Dates:* 8 a.m.-8:30 a.m., February 19, 2002 (Open), 8:40 a.m.-5 p.m., February 19, 2002 (Closed), 8 a.m.-5 p.m., February 20, 2002 (Closed).

*Place:* Loews L'Enfant Plaza Hotel, 480 L'Enfant SW., Washington DC 20024.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the  Determination of the Deputy Director for Program Management, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to RFA OH-02-001.

**FOR FURTHER INFORMATION CONTACT:**

Pervis Major, Ph.D., Scientific Review Administrator, National Institute for Occupational Safety and Health, CDC, 1095 Willowdale Road, M/S B228, telephone (304) 285-5979.

The Director, Management Analysis and Services Office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: January 30, 2002.

Alvin Hall,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).